Heparin-binding properties of human serum spreading factor

Prior research has shown that human serum spreading factor (SF) is a glycoprotein that influences cell attachment and migration in culture. It was already known that SF promotes cell spreading and affects growth processes. However, no prior work had resolved whether SF binds to heparin under physiological conditions. This gap motivated an investigation into the heparin-binding properties of SF. Earlier studies indicated SF could be purified using chromatographic methods. Yet, the question of heparin affinity remained unresolved. This uncertainty drove experiments to test if SF binding could be altered by environmental factors like urea, heat, or acid. The biological activity of SF is tied to its ability to bind substrates, making this a critical area for study. Understanding these interactions could clarify SF's role in cellular processes.

The aim of the study was to determine whether human serum spreading factor binds to heparin under physiological conditions. Researchers sought to examine if urea treatment, heat, or acid could alter SF's heparin-binding properties. They also wanted to assess how these changes affect SF's biological activity. The motivation stemmed from the need to understand SF's functional mechanisms in cell culture. By testing SF's interaction with heparin-Sepharose, the team aimed to clarify its binding behavior. They hypothesized that urea treatment might modify SF's structure and function. The study also aimed to investigate SF's heparin-binding properties in unfractionated plasma. This work sought to bridge a knowledge gap about SF's substrate interactions.

The study used chromatographic methods previously reported to purify SF from human plasma. Researchers tested SF's binding to heparin-Sepharose under physiological ionic strength and pH. They exposed purified SF to 8 M urea and examined changes in heparin affinity. After urea removal, they assessed if the altered properties persisted. The team also tested the effects of heat and acid on SF's heparin-binding behavior. Salt concentrations were measured to determine elution requirements from heparin-Sepharose. Biological activity was evaluated by observing cell spreading promotion. The experiments included both purified SF and SF in unfractionated plasma.

Purified SF did not bind to heparin-Sepharose under physiological conditions. Exposure to 8 M urea altered SF's heparin-binding properties. These changes remained after urea removal from SF solutions. Urea-treated SF bound to heparin under physiological conditions. Elution required salt concentrations of 0.4 M or higher at pH 7.0. Heat or acid treatment also altered SF's heparin-binding properties. Treated SF showed greatly decreased cell spreading-promoting activity. The reduced activity was linked to decreased substrate binding ability.

The authors found that native SF does not bind to heparin under physiological conditions. Urea, heat, or acid treatment alters SF's heparin-binding properties. These modifications persist even after removing the treatment agents. Altered SF binds to heparin and requires higher salt concentrations for elution. The study suggests that SF's biological activity depends on its ability to bind substrates. The authors propose that urea treatment disrupts SF's structure, affecting function. They suggest that SF's heparin-binding properties are modifiable by environmental factors. These findings trace directly to the claims in the abstract.